Tanja Fehm - Concepedia

Author

Tanja Fehm

Heinrich Heine University Düsseldorf ORCID

Also Known As

Antje Hahn, F Tanja, Fehm Tanja, Fehm, T., Fehm, Tanja, Fehm, Tanja N., Jean-Christophe Thery, Kln, Lianqiang Dong, M. Hauschild

Publications

34.1K

Citations

H-Index

171

Concepts

All Affiliations

Heinrich Heine University Düsseldorf University of Tübingen Düsseldorf University Hospital Universität Hamburg University Medical Center Hamburg-Eppendorf

About

Tanja Fehm is an author at Heinrich Heine University Düsseldorf specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	44	140	10.5K
2	Health Sciences	17	25	2.5K
3	Public Health	14	18	857
4	Nursing	6	6	188
5	Engineering	3	3	85

Tanja Fehm

356

Publications

28.2K

Citations

H-Index

Page 1

	Year	Citations
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study Thorsten Kuehn, Ingo Bauerfeind, Tanja Fehm, The Lancet Oncology Sentinel-lymph-node BiopsySurgical OncologyBreast OncologyNeoadjuvant ChemotherapyCancer Detection	2013	1.4K
A Pooled Analysis of Bone Marrow Micrometastasis in Breast Cancer Stephan Braun, Florian D. Vogl, Bjørn Naume, New England Journal of Medicine	2005	1.4K
Systemic Spread Is an Early Step in Breast Cancer Yves Hüsemann, Jochen B. Geigl, Falk Schubert, Cancer Cell Breast OncologyMedicineSystemic SpreadPathologyBreast Cancer	2008	1.2K
Circulating Tumor Cells in Patients with Breast Cancer Dormancy Songdong Meng, Debasish Tripathy, Eugene P. Frenkel, Clinical Cancer Research	2004	965
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data François‐Clément Bidard, Dieter Peeters, Tanja Fehm, The Lancet Oncology Metastatic Breast CancerBreast OncologyClinical ValidityIndividual Patient DataMedicine	2014	815
Early dissemination seeds metastasis in breast cancer Hedayatollah Hosseini, Milan Obradović, Martin Hoffmann, Nature Breast OncologyMedicinePathologyBreast CancerOncology	2016	748
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients Bahriye Aktas, Mitra Tewes, Tanja Fehm, Breast Cancer Research	2009	729
Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients Brigitte Rack, Christian Schindlbeck, Julia Jückstöck, JNCI Journal of the National Cancer Institute	2014	601
Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer Gϋnter von Minckwitz, Holger Eidtmann, Mahdi Rezai, New England Journal of Medicine	2012	528
<i>HER-2</i> gene amplification can be acquired as breast cancer progresses Songdong Meng, Debasish Tripathy, Sanjay Shete, Proceedings of the National Academy of Sciences	2004	506

Page 1